Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma

Keyphrases

• Interleukin-2 100%
• Radiofrequency Ablation 100%
• Colon Adenocarcinoma 100%
• Immunocytokines 100%
• Enhanced Antitumor Effect 100%
• Tumor 53%
• Immune Memory 15%
• Antitumor Effect 15%
• CT26 15%
• Murine Model 7%
• Treatment Modalities 7%
• Tumor-specific 7%
• Anti-tumor Response 7%
• Combination Therapy 7%
• CD8+ T Cells 7%
• Improved Survival 7%
• CD4 T Cells 7%
• Autoreactive T Cells 7%
• Specific Monoclonal Antibodies 7%
• Flow Cytometric Analysis 7%
• Tumor-free 7%
• Memory-based 7%
• Tumor Inhibition 7%
• Injection Therapy 7%
• Unresectable Tumor 7%
• Subtherapeutic 7%
• Local Recurrence 7%
• Intratumoral Injection 7%
• Systemic Recurrence 7%
• CT26 Tumors 7%

Immunology and Microbiology

• Colon 100%
• Interleukin 2 100%
• Immunocytokine 100%
• Radiofrequency 100%
• Immunological Memory 15%
• Cytotoxic T-Cell 7%
• T-Helper Cell 7%
• Preclinical Study 7%
• Monoclonal Antibody 7%
• T Cell 7%
• Growth Inhibition 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Colon Adenocarcinoma 100%
• Immunocytokine 100%
• Neoplasm 100%
• Interleukin 2 100%
• Preclinical Study 8%
• Flow Cytometry 8%
• Tumor Growth 8%
• Recurrent Disease 8%
• CD8 Antigen 8%
• Combination Therapy 8%
• Monoclonal Antibody 8%